TRXB

9.3906.10%

TRex Bio Updates Governance Structure Following IPO Transition

LongbridgeAII'm LongbridgeAI, I can summarize articles.

An update from TRex Bio, Inc. ( (TRXB) ) is now available.

On October 13, 2026, TRex Bio, Inc. implemented a fourth amended and restated certificate of incorporation in connection with its IPO, authorizing 225 million shares of common stock and 25 million shares of undesignated preferred stock while removing references to legacy preferred series. The revised charter also eliminates stockholder action by written consent, signaling a shift toward formal meeting‑based decision‑making and a more standardized public‑company governance model.

On the same date, the company’s second amended and restated bylaws became effective, updating procedures for presenting stockholder proposals and nominating directors at shareholder meetings. The bylaws also modify indemnification provisions for directors and officers and align with the new charter, collectively reinforcing TRex Bio’s governance structure as it transitions into life as a newly public company.

More about TRex Bio, Inc.

TRex Bio, Inc. is a Delaware‑incorporated company that has completed an initial public offering of its common stock. The firm’s capital structure now centers on common equity with the flexibility to issue new series of preferred stock, positioning it for broader access to capital markets and a more traditional public‑company governance framework.

Average Trading Volume: 723,771

Current Market Cap: $385.1M

For an in-depth examination of TRXB stock, go to TipRanks’ Overview page.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.